United Kingdom’s National Institute for Health and Care Excellence (NICE) has provisionally recommended ocriplasmin (Jetrea, ThromboGenics NV) for reimbursement within the National Health Service (NHS).
What is your diagnosis?
The Cole Eye Institute will present a Retina Summit CME symposium immediately before the ARVO 2013 annual meeting.
Optos plc has received 510(k) clearance from the FDA for microperimetry as part of the OptosOCT SLO.
Gene therapy is making headway in inherited retinal diseases that were previously thought to be untreatable.